TC
ENZ

TFS Capital’s Enzo Biochem, Inc. ENZ Stock Holding History

TFS Capital’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-28,325
Closed -$313K – 374
2017
Q2 		$313K Buy
28,325
+13,101
+86% +$122K 0.12% 335
2017
Q1 		$127K Sell
15,224
-1,985
-12% -$14K 0.04% 563
2016
Q4 		$119K Buy
17,209
+5,937
+53% +$37.9K 0.03% 618
2016
Q3 		$57K Sell
11,272
-138,750
-92% -$829K 0.01% 703
2016
Q2 		$896K Sell
150,022
-148,535
-50% -$824K 0.16% 203
2016
Q1 		$1.36M Sell
298,557
-149,490
-33% -$665K 0.2% 162
2015
Q4 		$2.02M Buy
448,047
+363,680
+431% +$1.54M 0.22% 162
2015
Q3 		$267K Sell
84,367
-323,278
-79% -$981K 0.03% 681
2015
Q2 		$1.24M Buy
407,645
+129,614
+47% +$364K 0.12% 279
2015
Q1 		$820K Sell
278,031
-57,059
-17% -$187K 0.08% 407
2014
Q4 		$1.49M Sell
335,090
-50,878
-13% -$243K 0.14% 204
2014
Q3 		$1.99M Sell
385,968
-109,836
-22% -$586K 0.17% 180
2014
Q2 		$2.6M Buy
495,804
+31,760
+7% +$137K 0.2% 130
2014
Q1 		$1.93M Buy
+464,044
New +$1.59M 0.13% 232

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TFS Capital's ENZ Position: Q3 2017 in Review

TFS Capital sold out of Enzo Biochem, Inc. (ENZ) in Q3 2017, closing a stake of 28,325 shares — an estimated $313K sold.

TFS Capital first reported a position in ENZ in Q1 2014 and held it in 14 quarters. The position peaked at $2.6M in Q2 2014. 116 funds tracked by Wall St. Rank hold ENZ as of Q3 2017.

  • TFS Capital reported no remaining Enzo Biochem, Inc. position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 28,325 Enzo Biochem, Inc. shares in Q3 2017, an estimated $313K.
  • TFS Capital first reported a position in Enzo Biochem, Inc. in Q1 2014 and held it in 14 quarters.
  • TFS Capital's Enzo Biochem, Inc. position peaked at $2.6M in Q2 2014.
  • 116 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.